[HTML] nature.com

[HTML][HTML] Equivariant 3D-conditional diffusion model for molecular linker design

I Igashov, H Stärk, C Vignac, A Schneuing… - Nature Machine …, 2024 - nature.com
Fragment-based drug discovery has been an effective paradigm in early-stage drug
development. An open challenge in this area is designing linkers between disconnected …
被引用次数：99 相关文章

Equivariant 3D-Conditional Diffusion Models for Molecular Linker Design

I Igashov, H Stärk, C Vignac, V Garcia Satorras… - arXiv e …, 2022 - ui.adsabs.harvard.edu
Fragment-based drug discovery has been an effective paradigm in early-stage drug
development. An open challenge in this area is designing linkers between disconnected …

Equivariant 3D-Conditional Diffusion Models for Molecular Linker Design

I Igashov, H Stärk, C Vignac, VG Satorras, P Frossard… - openreview.net
Fragment-based drug discovery has been an effective paradigm in early-stage drug
development. An open challenge in this area is designing linkers between disconnected …

Equivariant 3D-Conditional Diffusion Models for Molecular Linker Design

I Igashov, H Stärk, C Vignac, VG Satorras… - arXiv preprint arXiv …, 2022 - arxiv.org
Fragment-based drug discovery has been an effective paradigm in early-stage drug
development. An open challenge in this area is designing linkers between disconnected …

Equivariant 3D-Conditional Diffusion Models for Molecular Linker Design

I Igashov - cirm-math.fr
Fragment-based drug discovery has been an effective paradigm in earlystage drug
development. An open challenge in this area is designing linkers between disconnected …

Equivariant 3D-Conditional Diffusion Models for Molecular Linker Design

I Igashov, H Stärk, C Vignac, VG Satorras… - NeurIPS 2022 AI for … - openreview.net
Fragment-based drug discovery has been an effective paradigm in early-stage drug
development. An open challenge in this area is designing linkers between disconnected …